Delivery Order SPE2DB22D3501-SPE2DB24FUT70
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of COSENTYX SENSOREADY 150 MG PENML. The $8,952.58 delivery order has a completion date of March 1, 2024 and was awarded on February 29, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a $26,881.05 firm fixed price delivery order by the Defense Logistics Agency (DLA). This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $15,047.26 firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide COSENTYX SNRDY 300MG DOSE-2PENML pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00, which serves as the primary vehicle for Amerisourcebergen to deliver pharmaceuticals and medical supplies to DLA Troop Support Medical...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide COSENTYX SNRDY 300MG DOSE-2PENML pharmaceuticals. The contract has a potential value of $4,734.61 and a completion date of March 8, 2024. This delivery order contract is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA with a potential value of $999,999,999.00 and a...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a $6,087.80 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide COSENTYX SNRDY 300MG DOSE-2PENML pharmaceutical products. This delivery order contract has a performance period through March 8, 2024 and is not designated as a set-aside. Amerisourcebergen Drug Corp has an existing indefinite delivery contract (IDC) with DLA, with a potential value of up to...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical under a larger indefinite delivery contract (IDC). The award is for the delivery of COSENTYX SENSOREADY 150 MG PENML, a specialty pharmaceutical product, with a ceiling value of $10,245.11. The contract is a firm fixed price arrangement with an ultimate completion date of April 2, 2024....
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $6,544.95 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide COSENTYX SNRDY 300MG DOSE-2PENML pharmaceutical products. This delivery order is issued under Amerisourcebergen's existing indefinite delivery contract (IDC) with DLA, which has a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, received a firm fixed price delivery order contract from the U.S. Defense Logistics Agency (DLA) to provide COSENTYX SNRDY 300MG DOSE-2PENML pharmaceutical products. The contract, valued at $3,073.42, has a completion date of February 20, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a $1,521.95 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation, for the supply of COSENTYX SENSOREADY 150 MG PEN medication. This delivery order has a completion date of February 21, 2024. Amerisourcebergen Drug Corp is the prime contractor and has previously been awarded an indefinite delivery contract (IDC) by DLA with a potential value of $999,999,999.00 and a...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of COSENTYX SENSOREADY 150 MG PEN ML pharmaceutical products. The $3,043.90 delivery order has an ultimate completion date of March 21, 2024 and does not utilize any set-aside designations. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued up to $999,999,999.00 through...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB24FUT70Delivery Order
Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide COSENTYX SENSOREADY 150 MG PENML pharmaceutical products. The $15,984.50 contract has a completion date of March 1, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp is the prime contractor and there are no major subcontractors listed. This delivery order is issued under an existing indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00, that serves as the primary vehicle for Amerisourcebergen to supply pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.0k | 2/29/24 |